Skip to content
Research Article Open access CC BY 3.0

Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes

Alok K. Gupta, Eric Ravussin, Darcy L. Johannsen, April J. Stull, William T. Cefalu, William D. Johnson

Journal of Advances in Medicine and Medical Research · pp. 413–423 · Published 30 May 2012

10.9734/BJMMR/2012/1479

Abstract

Aims: To elucidate if endothelial dysfunction is an early CV risk marker in obese men and women with prediabetes. Study Design: Cross-sectional study. Place and Duration of Study: Clinical Research Unit, Pennington Biomedical Research Center, Baton Rouge, LA. United States. Methodology: Overweight and obese status denotes an increasing adipose tissue burden which spills over into ectopic locations, including the visceral compartment, muscle and liver. Associated co-morbidities enhance cardiovascular (CV) risk. Endothelium which is the largest receptor-effector end-organ in our bodies, while responding to numerous physical and chemical stimuli maintains vascular homeostasis. Endothelial dysfunction (ED) is the initial perturbation, which precedes fatty streak known to initiate atherosclerosis: insidious process which often culminates as sudden catastrophic CV adverse event. Asymptomatic men and women; [n=42] coming in after an overnight fast had demographic, anthropometric, clinical chemistry and resting endothelial function [EF: increased test finger peripheral arterial tone (PAT) relative to control; expressed as relative hyperemia index (RHI)] assessments. Results: Adults with desirable weight [n=12] and overweight [n=8] state, had normal fasting plasma glucose [Mean(SD)]: FPG [91.1(4.5), 94.8(5.8) mg/dL], insulin [INS, 2.3(4.4), 3.1(4.8) µU/ml], insulin sensitivity by homeostasis model assessment [HOMA-IR, 0.62(1.2), 0.80(1.2)] and desirable resting clinic blood pressure [SBP/DBP, 118(12)/74(5), 118(13)/76(8) mmHg]. Obese adults [n=22] had prediabetes [FPG, 106.5(3.5) mg/dL], hyperinsulinemia [INS 18.0(5.2) µU/ml], insulin resistance [HOMA-IR 4.59(2.3)], prehypertension [PreHTN; SBP/DBP 127(13)/81(7) mmHg] and endothelial dysfunction [ED; reduced RHI 1.7(0.3) vs. 2.4(0.3); all p<0.05]. Age-adjusted RHI correlated with BMI [r=-0.53; p<0.001]; however, BMI-adjusted RHI was not correlated with age [r=-0.01; p=0.89]. Conclusion: Endothelial dysfunction reflective of cardiometabolic changes in obese adults can be an early risk marker for catastrophic CV events.

Fasting plasma glucose healthy adults reverse cholesterol transport pathway insulin resistance; body weight relative hyperemia index

References (40)

  1. 1 Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man [DOI]
  2. 2 Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study [DOI]
  3. 3 Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) [DOI]
  4. 4 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [DOI]
  5. 5 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report [DOI]
  6. 6 Atherosclerosis — An Inflammatory Disease [DOI]
  7. 7 Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
  8. 8 The pathogenesis of atherosclerosis: a perspective for the 1990s [DOI]
  9. 9 Standards of Medical Care in Diabetes [DOI]
  10. 10 The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function [DOI]
  11. 11 Endothelial Function and Dysfunction [DOI]
  12. 12 Role of Endothelial Dysfunction in Atherosclerosis [DOI]
  13. 13 Atherosclerosis is an inflammatory disease [DOI]
  14. 14 Standards of Medical Care in Diabetes—2007 [DOI]
  15. 15 Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia [DOI]
  16. 16 Atherosclerosis — An Inflammatory Disease [DOI]
  17. 17 Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude [DOI]
  18. 18 Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events [DOI]
  19. 19 Adipose Tissue Dysfunction in Obesity [DOI]
  20. 20 The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance [DOI]
  21. 21 Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat [DOI]
  22. 22 Type 2 Diabetes as a “Coronary Heart Disease Equivalent” [DOI]
  23. 23 Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose [DOI]
  24. 24 Endothelial Nitric Oxide Production and Insulin Sensitivity [DOI]
  25. 25 Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent? [DOI]
  26. 26 Ectopic fat and cardiovascular disease: What is the link? [DOI]
  27. 27 Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile [DOI]
  28. 28 An overview of reverse cholesterol transport.
  29. 29 Increased reverse cholesterol transport in athletes [DOI]
  30. 30 Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population [DOI]
  31. 31 Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study [DOI]
  32. 32 Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu [DOI]
  33. 33 Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events [DOI]
  34. 34 Comparison of Peripheral Endothelial Function in Shift Versus Nonshift Workers [DOI]
  35. 35 Prediabetes is associated with abnormal circadian blood pressure variability [DOI]
  36. 36 The Acute Effect of Various Glycemic Index Dietary Carbohydrates on Endothelial Function in Nondiabetic Overweight and Obese Subjects [DOI]
  37. 37 An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis [DOI]
  38. 38 Peripheral arterial tone [DOI]
  39. 39 Tangier disease as a test of the reverse cholesterol transport hypothesis [DOI]
  40. 40 Endothelial Function [DOI]

Cited by 92

Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model.

Doganay S, Yanar S, Bolat İ · Sci Rep · 2026

Effects of a 6-Week Concurrent Training Program Combining Resistance and Various Modalities of Aerobic Exercise in Obese Women with Prehypertension: A Randomized Controlled Trial.

Yu J, Lee E, Choi JH · Metabolites · 2025

Involvement of circulating microRNAs in the pathogenesis of atherosclerosis in young patients with obesity.

Mazgutova N, Witvrouwen I, Czippelova B · Physiol Res · 2024

Inhibition of proline-rich tyrosine kinase 2 restores cardioprotection by remote ischaemic preconditioning in type 2 diabetes.

Erkens R, Duse DA, Brum A · Br J Pharmacol · 2024

Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.

Cincotta AH. · Int J Mol Sci · 2023

Microvascular and Endothelial Dysfunction in Prediabetes.

Lamprou S, Koletsos N, Mintziori G · Life (Basel) · 2023

Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.

Cincotta AH, Cersosimo E, Alatrach M · Int J Mol Sci · 2022

Effects of acute arginine supplementation on neuroendocrine, metabolic, cardiovascular, and mood outcomes in younger men: A double-blind, placebo-controlled trial.

Apolzan JW, Stein JA, Rood JC · Nutrition · 2022

Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.

Ezrokhi M, Zhang Y, Luo S · Int J Mol Sci · 2021

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics.

Hromadnikova I, Kotlabova K, Dvorakova L · Int J Mol Sci · 2020

Showing 34 of 92 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

65

Page views

0

PDF downloads

4

Outbound clicks

92

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.